Peripheral Vascular Disorders
News from the FDA/CDC
FDA grants sirolimus-eluting balloon breakthrough device designation for PAD
Video
In PAD, dropping statins ups death risk 43%
PARIS – Statin adherence saves lives in peripheral arterial disease.
From the Journals
AHA highlights limitations of perfusion testing for critical limb ischemia
News from the FDA/CDC
FDA update: Higher late mortality with paclitaxel-coated devices
From the Journals
Atherosclerotic disease risk persists decades after smoking cessation
From the Journals
Microvascular disease: An independent and exacerbating risk factor for amputation
The presence of microvascular disease plus peripheral artery disease resulted in a more than 20-fold increased risk of amputation than MVD or PAD...
Latest News
Revascularization plus exercise is most effective for intermittent claudication
From the Journals
Higher serum leptin levels associated with PAD
Serum leptin levels are positively and independently associated with PAD.
From the Journals
Ask patients, not devices, about impact of PAD
From the Journals
Paclitaxel drug-coated balloons appear safe for PAD treatment
There was no significant difference in all-cause mortality between DCB and PTA patients through 5 years.
From the Journals
Diabetic kidney disease, retinopathy associated with PAD in patients with foot ulcers
Patients with diabetic foot ulcers have a high incidence of associated chronic vascular disease, including kidney disease, retinopathy, and PAD....